ByLatest Stories
Don’t miss our hot and upcoming stories
Can Merck’s $3 Billion Restructuring Drive Sustainable Growth Amidst Patent Challenges?
About MerckMerck & Co., Inc. (MSD outside US & Canada) is a global biopharmaceutical company…
Is Bristol Myers Squibb’s $300M Immunology Venture with Bain Capital Set to Pioneer Next-Gen Autoimmune Therapies?
Key Highlights About Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical leader focused on innovative medicines…
How Is GSK’s Robust Q2 2025 Growth Powering Next-Gen Specialty Medicines and Vaccine Innovation?
Key Highlights Specialty Medicines Fuel Strong Market MomentumGSK’s specialty portfolio, notably in Respiratory, Immunology &…
Is Mayo Clinic’s NVIDIA Blackwell-Powered DGX SuperPOD the Next Leap in AI-Driven Clinical Innovation?
Key Highlights NVIDIA Blackwell Infrastructure: High-Performance Compute for Healthcare AIThe NVIDIA DGX SuperPOD system delivers…